Log in to save to my catalogue

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_86208d0971bf4ed2a80bc56f650c0589

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants

About this item

Full title

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2021-09, Vol.12 (1), p.5652-5652, Article 5652

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

Subjects

Subjects and topics

More information

Scope and Contents

Contents

The emergence of numerous variants of SARS-CoV-2, the causative agent of COVID-19, has presented new challenges to the global efforts to control the COVID-19 pandemic. Here, we obtain two cross-neutralizing antibodies (7D6 and 6D6) that target
Sarbecoviruses’
receptor-binding domain (RBD) with sub-picomolar affinities and potently neutralize...

Alternative Titles

Full title

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_86208d0971bf4ed2a80bc56f650c0589

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_86208d0971bf4ed2a80bc56f650c0589

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-021-25997-3

How to access this item